News Releases
July 29, 2026
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement
February 8, 2024
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
February 2, 2024
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
December 7, 2023
Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023
November 9, 2023
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Displaying 1 - 12 of 226